Vittorina Zagonel Selected Research

Vittorina Zagonel Research Topics

Disease

77	Neoplasms (Cancer) 04/2024 - 01/2002
41	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 11/2008
33	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 12/2010
19	Disease Progression 01/2022 - 08/2013
16	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2016
16	Glioma (Gliomas) 09/2021 - 12/2010
11	Neoplasm Metastasis (Metastasis) 04/2024 - 05/2012
11	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 05/2011
11	Prostatic Neoplasms (Prostate Cancer) 03/2021 - 01/2015
8	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2002
7	Adenocarcinoma 01/2022 - 08/2011
7	Colonic Neoplasms (Colon Cancer) 01/2020 - 10/2009
6	Microsatellite Instability 08/2023 - 11/2019
5	Carcinoma (Carcinomatosis) 10/2023 - 11/2019
5	Sarcoma (Soft Tissue Sarcoma) 02/2023 - 03/2016
5	Stomach Neoplasms (Stomach Cancer) 10/2021 - 01/2012
4	Rectal Neoplasms (Rectal Cancer) 04/2024 - 01/2019
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2014
4	Fatigue 07/2021 - 06/2016
4	Neutropenia 01/2019 - 03/2003
4	Breast Neoplasms (Breast Cancer) 01/2018 - 03/2003
4	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 06/2008
3	Infections 01/2023 - 01/2021
3	Cholangiocarcinoma 01/2022 - 04/2017
3	Turcot syndrome 01/2021 - 01/2020
3	Edema (Dropsy) 01/2021 - 09/2013
3	Hypertension (High Blood Pressure) 07/2018 - 01/2013
2	Clinical Deterioration 01/2023 - 03/2012
2	Melanoma (Melanoma, Malignant) 02/2022 - 01/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2002
2	Leiomyosarcoma 01/2022 - 01/2020
2	Ependymoma 12/2021 - 01/2013
2	Circulating Neoplastic Cells 01/2021 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 12/2020 - 06/2003

Drug/Important Bio-Agent (IBA)

21	Bevacizumab (Avastin)FDA Link 02/2020 - 12/2010
18	Temozolomide (Temodar)FDA LinkGeneric 05/2022 - 08/2011
18	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 01/2011
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
11	regorafenibIBA 01/2022 - 01/2018
10	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2018
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2012
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 10/2014
9	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 01/2014
9	Irinotecan (Camptosar)FDA LinkGeneric 02/2020 - 12/2010
7	Monoclonal AntibodiesIBA 01/2022 - 12/2010
7	Docetaxel (Taxotere)FDA Link 01/2021 - 01/2015
7	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2012
6	Leucovorin (Folinic Acid)FDA Link 12/2023 - 01/2014
6	pembrolizumabIBA 01/2022 - 01/2018
6	Trastuzumab (Herceptin)FDA Link 12/2020 - 01/2011
5	Panitumumab (Vectibix)FDA Link 12/2023 - 06/2016
5	NivolumabIBA 01/2023 - 01/2022
5	Cetuximab (Erbitux)FDA Link 11/2021 - 11/2015
5	Angiogenesis InhibitorsIBA 05/2020 - 01/2013
5	Capecitabine (Xeloda)FDA Link 01/2020 - 10/2009
5	fotemustine (Muphoran)IBA 12/2018 - 01/2014
4	Thyroid HormonesIBA 10/2023 - 01/2018
4	cabozantinibIBA 01/2023 - 07/2018
4	PlatinumIBA 01/2022 - 10/2009
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2012
4	Lomustine (CCNU)FDA Link 01/2021 - 01/2014
4	Lapatinib (GW572016)FDA Link 12/2020 - 11/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 12/2010
3	IpilimumabIBA 01/2023 - 01/2022
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 05/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2002
3	depatuxizumab mafodotinIBA 06/2021 - 01/2020
3	Sunitinib (Sutent)FDA Link 01/2021 - 06/2015
3	enzalutamideIBA 01/2021 - 07/2015
3	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2013
3	Circulating Tumor DNAIBA 01/2021 - 01/2018
3	XELOXIBA 01/2020 - 11/2014
3	erucylphosphocholineIBA 07/2019 - 01/2016
3	Cisplatin (Platino)FDA LinkGeneric 02/2014 - 08/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2024 - 01/2021
2	AntigensIBA 01/2023 - 11/2008
2	O-(6)-methylguanineIBA 05/2022 - 01/2002
2	MethyltransferasesIBA 05/2022 - 01/2002
2	VaccinesIBA 01/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	TrabectedinIBA 01/2022 - 01/2019
2	Protein Isoforms (Isoforms)IBA 10/2021 - 10/2021
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2016
2	abirateroneIBA 01/2021 - 01/2015
2	pertuzumabIBA 12/2020 - 01/2020

Therapy/Procedure

53	Therapeutics 01/2023 - 03/2003
40	Drug Therapy (Chemotherapy) 12/2023 - 09/2002
19	Radiotherapy 01/2023 - 09/2002
14	Palliative Care (Palliative Therapy) 04/2024 - 12/2011
10	Immunotherapy 12/2023 - 01/2017
9	Castration 01/2021 - 01/2015
6	Chemoradiotherapy 05/2022 - 05/2015
6	Adjuvant Chemotherapy 12/2020 - 11/2014
4	Nutritional Support (Artificial Feeding) 01/2022 - 01/2016
3	Ambulatory Care (Outpatient Care) 02/2024 - 05/2016
3	Neoadjuvant Therapy 03/2023 - 02/2014
3	Aftercare (After-Treatment) 01/2022 - 01/2018
3	Precision Medicine 12/2020 - 01/2017
2	Combined Modality Therapy 09/2021 - 12/2020
2	Metastasectomy 02/2021 - 01/2019